Around 5% of the total share number has already changed hands this morning at prices up to 7 c. That is not all that many, nor is the price at a level that would induce LT holders to sell.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
